McKesson Corporation (MCK)

NYSE · Healthcare · Medical Distribution
$1,069.43+0.68%As of 2026-11-22 · USD
Last session low $1,067.43Last session high $1,088.14
52-week low $723.6852-week high $1,121.50
Market cap
$123.47B
Sector
Healthcare
P/E (TTM)
27.6x
Dividend yield
0.35%
Next earnings
2027-02-03 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)62.9In the neutral range (30 to 70)
MACD (12, 26, 9)32.33Below its signal line (34.67); histogram -2.33
Bollinger %B (20, 2)62%Inside the bands (951.75 to 1,140.55)
SMA 201,046.15Price is 2.2% above
SMA 50974.57Price is 9.7% above
SMA 200879.87Price is 21.5% above
ATR (20)2.39% of priceAverage true range per day
52-week position87%In the upper part of the 723.68 to 1,121.50 range

About McKesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.

Insider filings, 90 daysNo purchases and 2 sales (about $896K).
Latest fiscal yearEnded 2026-03-31: revenue of $403.43B and an operating margin of 1.6%.
Next earnings reportExpected on 2027-02-03 (the date is an estimate).

More in Medical Distribution